Integrum (publ) announced that the company has received market approval for the OPRA®? Implant System in Israel. In March, Integrum entered a commercial agreement with AMI Technologies to Introduce the OPRA®?

Im plant System to the Israeli market. With the market approval in place, AMI Technologies can now start providing OPRA®? to hospitals in the region.